HK2 and neoplasm: In tumor vascular remodeling, pericyte-expressed hexokinase 2 (HK2) impairs vascular support by activating ROCK2-MLC2, while inhibition of HK2 activity improves vascular function and enhances the delivery of chemotherapy drugs.58